FIELD: milling equipment for producing of finely-dispersed substances used as inhalation medicinal drugs.
SUBSTANCE: method involves milling crystalline substance by atomizing thereof with the use of milling medium including helium having temperature within the range of from -300C to -1200C. Helium may be used as milling medium. Crystalline substance may include powdered medicinal drug, for example, crystalline substance may be triamcinolone acetonide. Milled product may comprise amorphous phase content below 5%. Milled product may comprise amorphous phase content below 2% or below 1%. Milled product may include powdered medicinal drug adapted for inhalation, with average particle size of milled product being less than 10 microns. Crystalline substance is substantially free from amorphous phase, has average particle size of 1 micron, and may be triamcinolone acetonide.
EFFECT: increased efficiency in producing of finely-dispersed substance from crystalline substance.
11 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF GRINDING FOR PREPARING FINELY DIVIDED MEDICAL SUBSTANCES | 1999 |
|
RU2219908C2 |
METHOD OF GRINDING CRYSTALLINE POWDER MATERIAL | 2009 |
|
RU2423182C1 |
MEDICINAL PREPARATION ON CARRIER | 1992 |
|
RU2097027C1 |
METHOD FOR PRODUCING MEDICINAL AGENT ON CARRIER HAVING HIGH RATE OF SOLUBILITY | 0 |
|
SU1837868A3 |
METHOD OF PREPARING POWDERED WATER-SOLUBLE CELLULOSE DERIVATIVE | 2001 |
|
RU2291155C2 |
POWDERED WATER-SOLUBLE CELLULOSE DERIVATIVE AND A METHOD FOR PREPARATION THEREOF | 2001 |
|
RU2291156C2 |
FINE-GRAINED ALKALI-EARTH TITANATES AND METHOD OF PRODUCING SAID TITANATES USING TITANIUM OXIDE PARTICLES | 2005 |
|
RU2373154C2 |
INHALATION COMPOSITIONS CONTAINING MONTELEUKAST ACID AND PDE-4 INHIBITOR OR INHALATION CORTICOSTEROID | 2008 |
|
RU2470639C2 |
AGGREGATED PARTICLES | 2013 |
|
RU2666963C2 |
PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF | 2013 |
|
RU2663117C2 |
Authors
Dates
2004-08-20—Published
1999-12-01—Filed